PAMAM dendrimer was also used to deliver antisense oligonucleotides targeting the vascular endothelial growth factor VEGF-ASODN to inhibit the tumor vascularization of breast tumor tissue using a human breast tumor xenograft mice model [225]. Here, VEGFA is linked to breast neoplasm.